Site içinde arama yapın

bir ses eklendi Health

2025-05-08 08:45:53

Roche’s TNKase Revolutionizes Stroke Care with FDA Approval

Roche has made history with the FDA approval of TNKase (tenecteplase), the first new acute ischemic stroke drug in nearly 30 years. The drug offers a faster, easier-to-administer alternative to existing stroke treatments and is set to change the standard of care for acute ischemic stroke (AIS) patients. This approval signifies a turning point in the evolution of acute ischemic...

0 Yorumlar 0 hisse senetleri 154 Views 0 önizleme